Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a case report

BACKGROUND: Immune checkpoint inhibitor (ICI) combined with chemotherapy has exhibited promising results in small sample studies of pancreatic cancer patients. The efficacy of toripalimab, a programmed cell death protein 1 (PD-1) monoclonal antibody has been explored in the previous studies and it w...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jianping, Chen, Xi, Cheng, Ke, Lv, Wanrui, Cao, Dan, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985276/
https://www.ncbi.nlm.nih.gov/pubmed/36870985
http://dx.doi.org/10.1186/s12883-023-03140-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985276/
https://www.ncbi.nlm.nih.gov/pubmed/36870985
http://dx.doi.org/10.1186/s12883-023-03140-7

Ejemplares similares